Financials

  • Market Capitalization 3.99 M
  • Employee 3
  • Founded 2010
  • CEO N/A
  • Website www.silopharma.com
  • Headquarter Nevada, United States
  • FIGI BBG002D1DZ06
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.05
Price to sales ratio
2.64

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4974
REVB
Revelation Biosciences, Inc. - Common Stock
1.05 USD+1.94%-4.55%+5.00%-23.91%4.18 M USD
4978
TCRT
Alaunos Therapeutics, Inc. - Common Stock
1.61 USD-3.01%-9.04%-12.97%-39.68%4.09 M USD
4989
MBIO
Mustang Bio, Inc. - Common Stock
0.54 USD-1.82%-5.26%-8.47%-37.79%3.91 M USD
4995
PHGE
BiomX Inc. COmmon Stock
0.14 USD+7.69%+7.69%-22.22%-97.39%3.74 M USD

Frequently asked questions about Silo Pharma, Inc. Common Stock

What is the Silo Pharma, Inc. Common Stock stock price today?

The current price of Silo Pharma, Inc. Common Stock (SILO) is 2.51. Over the past 24 hours, the stock has changed by -1.18%. Follow the SILO chart for real-time price dynamics.

What is the stock ticker of Silo Pharma, Inc. Common Stock?

Silo Pharma, Inc. Common Stock trades under the ticker SILO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Silo Pharma, Inc. Common Stock stock going up?

SILO has changed by -8.06% over the last week, -41.36% over the last month, and +311.48% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Silo Pharma, Inc. Common Stock?

Silo Pharma, Inc. Common Stock currently has a market capitalization of 3.99 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Silo Pharma, Inc. Common Stock earnings last quarter?

Last quarter, Silo Pharma, Inc. Common Stock reported earnings of -0.76 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Silo Pharma, Inc. Common Stock revenue for the last quarter?

Silo Pharma, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Silo Pharma, Inc. Common Stock net income for the last quarter?

Silo Pharma, Inc. Common Stock reported net income of -832.83 K for the last quarter. The previous quarter showed -1.65 M, which means net income changed by +49.44%.

How many employees does Silo Pharma, Inc. Common Stock have?

As of the latest available data, Silo Pharma, Inc. Common Stock has 3 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Silo Pharma, Inc. Common Stock stock?

You can buy Silo Pharma, Inc. Common Stock (SILO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Silo Pharma, Inc. Common Stock stock?

Investing in Silo Pharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SILO chart and related analysis on metatrader.com as part of your research.

News